111 related articles for article (PubMed ID: 8911690)
1. Loss of Raf-1-binding activity of v-Ha-Ras by the deletion of amino acid residues 64-72 and 143-151.
Hiwasa T; Kasama M; Nakadai T; Sawada T; Sakiyama S
Cell Signal; 1996 Aug; 8(5):393-6. PubMed ID: 8911690
[TBL] [Abstract][Full Text] [Related]
2. Identification of discrete segments of human Raf-1 kinase critical for high affinity binding to Ha-Ras.
Ghosh S; Bell RM
J Biol Chem; 1994 Dec; 269(49):30785-8. PubMed ID: 7983008
[TBL] [Abstract][Full Text] [Related]
3. Interaction of activated Ras with Raf-1 alone may be sufficient for transformation of rat2 cells.
Stang S; Bottorff D; Stone JC
Mol Cell Biol; 1997 Jun; 17(6):3047-55. PubMed ID: 9154803
[TBL] [Abstract][Full Text] [Related]
4. Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues.
Chuang E; Barnard D; Hettich L; Zhang XF; Avruch J; Marshall MS
Mol Cell Biol; 1994 Aug; 14(8):5318-25. PubMed ID: 8035810
[TBL] [Abstract][Full Text] [Related]
5. Ras interaction with two distinct binding domains in Raf-1 may be required for Ras transformation.
Drugan JK; Khosravi-Far R; White MA; Der CJ; Sung YJ; Hwang YW; Campbell SL
J Biol Chem; 1996 Jan; 271(1):233-7. PubMed ID: 8550565
[TBL] [Abstract][Full Text] [Related]
6. Differential structural requirements for interaction of Ras protein with its distinct downstream effectors.
Akasaka K; Tamada M; Wang F; Kariya K; Shima F; Kikuchi A; Yamamoto M; Shirouzu M; Yokoyama S; Kataoka T
J Biol Chem; 1996 Mar; 271(10):5353-60. PubMed ID: 8621388
[TBL] [Abstract][Full Text] [Related]
7. Cysteine-rich region of Raf-1 interacts with activator domain of post-translationally modified Ha-Ras.
Hu CD; Kariya K; Tamada M; Akasaka K; Shirouzu M; Yokoyama S; Kataoka T
J Biol Chem; 1995 Dec; 270(51):30274-7. PubMed ID: 8530446
[TBL] [Abstract][Full Text] [Related]
8. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
Marshall M
Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
[TBL] [Abstract][Full Text] [Related]
9. Difference in the mechanism of interaction of Raf-1 and B-Raf with H-Ras.
Shinkai M; Masuda T; Kariya K; Tamada M; Shirouzu M; Yokoyama S; Kataoka T
Biochem Biophys Res Commun; 1996 Jun; 223(3):729-34. PubMed ID: 8687465
[TBL] [Abstract][Full Text] [Related]
10. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.
Rommel C; Radziwill G; Lovrić J; Noeldeke J; Heinicke T; Jones D; Aitken A; Moelling K
Oncogene; 1996 Feb; 12(3):609-19. PubMed ID: 8637718
[TBL] [Abstract][Full Text] [Related]
11. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the interaction of Raf-1 with ras p21 or 14-3-3 protein in intact cells.
Koyama S; Williams LT; Kikuchi A
FEBS Lett; 1995 Jul; 368(2):321-5. PubMed ID: 7628630
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
[TBL] [Abstract][Full Text] [Related]
14. Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with ras-dependent activation of Raf-1.
Hu CD; Kariya Ki; Kotani G; Shirouzu M; Yokoyama S; Kataoka T
J Biol Chem; 1997 May; 272(18):11702-5. PubMed ID: 9115221
[TBL] [Abstract][Full Text] [Related]
15. The Ras-related protein R-ras interacts directly with Raf-1 in a GTP-dependent manner.
Spaargaren M; Martin GA; McCormick F; Fernandez-Sarabia MJ; Bischoff JR
Biochem J; 1994 Jun; 300 ( Pt 2)(Pt 2):303-7. PubMed ID: 8002932
[TBL] [Abstract][Full Text] [Related]
16. Mutations that abolish the ability of Ha-Ras to associate with Raf-1.
Shirouzu M; Koide H; Fujita-Yoshigaki J; Oshio H; Toyama Y; Yamasaki K; Fuhrman SA; Villafranca E; Kaziro Y; Yokoyama S
Oncogene; 1994 Aug; 9(8):2153-7. PubMed ID: 8036000
[TBL] [Abstract][Full Text] [Related]
17. The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype.
Fridman M; Tikoo A; Varga M; Murphy A; Nur-E-Kamal MS; Maruta H
J Biol Chem; 1994 Dec; 269(48):30105-8. PubMed ID: 7982912
[TBL] [Abstract][Full Text] [Related]
18. Raf-1 N-terminal sequences necessary for Ras-Raf interaction and signal transduction.
Pumiglia K; Chow YH; Fabian J; Morrison D; Decker S; Jove R
Mol Cell Biol; 1995 Jan; 15(1):398-406. PubMed ID: 7799948
[TBL] [Abstract][Full Text] [Related]
19. Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor.
Herrmann C; Horn G; Spaargaren M; Wittinghofer A
J Biol Chem; 1996 Mar; 271(12):6794-800. PubMed ID: 8636102
[TBL] [Abstract][Full Text] [Related]
20. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
